Kentucky 2022 Regular Session

Kentucky Senate Bill SB126

Introduced
1/27/22  
Refer
1/27/22  

Caption

AN ACT relating to the establishment of emergency insulin programs and declaring an emergency.

Impact

The implementation of SB126 has the potential to significantly enhance public health outcomes in Kentucky by addressing the urgent need for accessible and affordable insulin. It targets an estimated 500,000 residents diagnosed with diabetes who may struggle to afford necessary medications. Furthermore, the law establishes mechanisms for pharmacies to dispense insulin and receive compensation, which may stabilize the market and encourage more effective distribution of this critical medication.

Summary

Senate Bill 126 establishes programs to improve access to insulin for individuals in Kentucky, particularly those in urgent need of it. The bill creates two primary initiatives: the 'Urgent-Need Insulin Program' and the 'Continuing Access to Insulin Program'. The former is designed to help individuals who require insulin immediately, while the latter addresses ongoing insulin needs. Both programs will be managed by the Cabinet for Health and Family Services, aiming to ensure that eligible residents can access insulin affordably.

Sentiment

The sentiment surrounding SB126 appears to be largely positive among advocates for healthcare access and diabetes awareness. Supporters view the bill as a critical step toward ensuring that vulnerable populations obtain the medications that are vital for their health. However, there may be concerns regarding the adequacy of funding and resources to support these programs, especially given the number of eligible individuals identified.

Contention

Notable points of contention regarding SB126 include the administrative penalties levied on manufacturers for noncompliance with the program's stipulations. Manufacturers are subject to escalating fines if they fail to adhere to the standards set forth in the bill, which has sparked discussions about the balance of regulation and market predictability. Moreover, the eligibility restrictions for accessing the insulin programs, particularly concerning insurance coverage and income thresholds, may lead to debates on fairness and accessibility.

Companion Bills

No companion bills found.

Similar Bills

KY HB141

AN ACT relating to the establishment of emergency insulin programs and declaring an emergency.

KY HB42

AN ACT relating to the establishment of emergency insulin programs and declaring an emergency.

KY HB806

AN ACT relating to pharmaceutical manufacturers.

KY SB27

AN ACT relating to pharmaceutical manufacturers.

KY HB274

AN ACT relating to the practice of pharmacy.

KY SB134

AN ACT relating to prescription drugs.

KY SB170

AN ACT relating to pharmacy.

KY SB68

AN ACT relating to prescription drugs.